[Pubmed] A patient treated with ofatumumab for myasthenia gravis in conjunction with systemic lupus erythematosus and th
Posté : 02 sept. 2024 12:00
Intractable Rare Dis Res. 2024 Aug 31;13(3):195-198. doi: 10.5582/irdr.2024.01022.
ABSTRACT
Myasthenia gravis (MG) is an autoimmune disease mediated by B cells and is associated with acetylcholine receptor (AChR) and muscle-specific receptor tyrosine kinase (MuSK) antibodies in the postsynaptic membrane at the neuromuscular junction. Anti-CD20 monoclonal antibodies, such as ofatumumab demonstrated promising disease control in MG patients. We presented the rare case of a 34-year-old female with acetylcholine receptor-positive myasthenia gravis (AChR-MG), concomitant with systemic lupus erythematosus (SLE) and metastatic thyroid carcinoma, who was treated with ofatumumab and exhibited improvements during follow-up.
PMID:39220275 | PMC:PMC11350205 | DOI:10.5582/irdr.2024.01022
Source: https://pubmed.ncbi.nlm.nih.gov/3922027 ... t9+e462414